Evidence map›Paper›PMID 42329014›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2026

The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis.

Miles D Hagner, Aaron Miller, Solanus De la Serna, Alan Arakkal, Joseph Cavanaugh, Alejandro Pezzulo, Nabeel Hamzeh, Philip Polgreen, Alicia Gerke

Abstract read
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miles D HagnerDepartment of Internal Medicine University of Iowa Carver College of Medicine.ORCID 0009-0000-3167-2836
Aaron MillerDepartment of Epidemiology University of Iowa College of Public Health, Iowa City; Department of Biostatistics University of Iowa College of Public Health.ORCID 0000-0002-6828-8966
Solanus De la SernaDepartment of Internal Medicine University of Iowa Carver College of Medicine.ORCID 0000-0002-6825-8927
Alan ArakkalDepartment of Biostatistics University of Iowa College of Public Health.ORCID 0000-0002-7001-493X
Joseph CavanaughDepartment of Biostatistics University of Iowa College of Public Health.ORCID 0000-0002-0514-7664
Alejandro PezzuloDepartment of Internal Medicine University of Iowa Carver College of Medicine.ORCID 0000-0001-7544-5109
Nabeel HamzehDepartment of Internal Medicine University of Iowa Carver College of Medicine.ORCID 0000-0001-7296-8975
Philip PolgreenDepartment of Internal Medicine University of Iowa Carver College of Medicine; Department of Epidemiology University of Iowa College of Public Health.ORCID 0000-0002-0630-5898
Alicia GerkeDepartment of Internal Medicine University of Iowa Carver College of Medicine.ORCID 0000-0002-8333-3403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimSarcoidosis is a systemic inflammatory syndrome of unknown cause characterized by granulomas, heterogeneous presentation, and variable clinical course. Diagnosis is often delayed, contributing to patient distress, increased healthcare costs, and potentially worse outcomes. Prior estimates of diagnostic delays rely largely on case-based studies, which may overestimate delays by failing to account for baseline care practices and common alternative diagnoses that may resemble sarcoidosis.

methodsWe conducted a retrospective population-based cohort study to characterize healthcare utilization before a sarcoidosis diagnosis and to identify risk factors associated with a diagnostic delay. Using longitudinal commercial, Medicare, and Medicaid healthcare insurance claims data from 2001-2022, we identified patients with sarcoidosis and evaluated diagnostic delay frequency, time to diagnosis, and potential missed opportunities for diagnosis. Secondary analysis compared diagnostic differences between pulmonary and cutaneous sarcoidosis.

results87,092 sarcoidosis cases were identified, of which 56% experienced at least one healthcare visit with a symptomatically similar diagnosis before sarcoidosis was diagnosed. The mean time to diagnosis was 44 days, defined as the interval between increased baseline healthcare utilization and a sarcoidosis diagnosis. Patients had an average of 2.5 visits prior to sarcoidosis diagnosis that represented potential missed diagnostic opportunities. Pulmonary involvement was associated with longer time to diagnosis and more missed opportunities compared to cutaneous sarcoidosis. Risk factors for delays included obesity, outpatient evaluation, weekend visits, Medicaid insurance, and treatment for symptoms commonly attributable to sarcoidosis. Diagnosis was unaffected by age, season, or rural vs urban setting. Within Medicaid, white individuals had the highest risk for a missed diagnostic opportunity, while Black individuals had the lowest.

conclusionsIn this large population-based study, diagnostic delays in sarcoidosis were shorter than previously reported, yet substantial missed opportunities remain. Identifying patient- and system-level risk factors may help reduce delays, prevent disease progression, and improve outcomes in sarcoidosis.

Identifiers

PMID42329014
PMCPMC13359006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.